Additionally, intratumoral infusion of CCL21 over-expressed DCs was shown to increase intratumoral CD8 T cell infiltration and reduce tumor burdens in a transgenic lung cancer mouse model (60). The gene discussed is CD8A; the disease is neoplasm.